Abstract
Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Current Drug Metabolism
Title:An Overview on the Pharmacokinetics of Quantum Dots
Volume: 14 Issue: 8
Author(s): Xianwei Meng, Li Qiang and Jianfei Wei
Affiliation:
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Abstract: Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Export Options
About this article
Cite this article as:
Meng Xianwei, Qiang Li and Wei Jianfei, An Overview on the Pharmacokinetics of Quantum Dots, Current Drug Metabolism 2013; 14 (8) . https://dx.doi.org/10.2174/138920021131400103
DOI https://dx.doi.org/10.2174/138920021131400103 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear Imaging and Early Breast Cancer Detection
Current Radiopharmaceuticals Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications
Current HIV Research Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry Approaches to Minimize Infection Risk in Blood Banking and Transfusion Practice
Infectious Disorders - Drug Targets Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine Interferon-α Treatment in Systemic Mastocytosis
Current Drug Targets Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
Current Organic Chemistry Platelet Activity in the Pathophysiology of Inflammatory Bowel Diseases
Current Drug Targets p53: Fighting Cancer
Current Cancer Drug Targets The Current Role of PET/CT in Radiotherapy Planning
Current Radiopharmaceuticals Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design Gene Therapy of Cancer with Interleukin-12
Current Pharmaceutical Design Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
Recent Patents on Anti-Cancer Drug Discovery Kinase Inhibitors in Multitargeted Cancer Therapy
Current Medicinal Chemistry Proresolution Mediators and Receptors: Novel Drug Targets for Enhancing Pharmacological Armamentarium against Periodontal Inflammation
Infectious Disorders - Drug Targets Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders
Current Gene Therapy The Role of Histone Demethylase GASC1 in Cancer and its Therapeutic Potential
Current Cancer Therapy Reviews Marine Peptides and Related Compounds in Clinical Trial+
Anti-Cancer Agents in Medicinal Chemistry